The inhibitory function evident for FCRL2 in healthy B cells (19) implies that its upregulation by indolent IGHV mutated CLL might also contribute to biological suppression in this favorable CLL subtype. Here, FCRL2 is linked to B-cell chronic lymphocytic leukemia.